Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-01-03 @ 12:58 AM
Study NCT ID:
NCT02210858
Status:
COMPLETED
Last Update Posted:
2018-06-04
First Post:
2014-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-05
Start Date Type:
ACTUAL
Primary Completion Date:
2004-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-05
First Submit QC Date:
None
Study First Post Date:
2014-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-31
Last Update Post Date:
2018-06-04
Last Update Post Date Type:
ACTUAL